Bristol-Myers Squibb Co
CELG_r0.038USD
+0.005+15.27%
收盘 09/19, 16:00（美东）报价延迟15分钟
0.00总市值
--市盈率 TTM
关于 Bristol-Myers Squibb Co 公司
百时美施贵宝公司是一家生物制药公司，致力于发现、开发和提供先进药物，帮助患者战胜严重疾病。该公司提供各种治疗类别的产品，包括肿瘤学、血液学、免疫学、心血管和神经科学。其医药产品包括化学合成或小分子药物、通过生物过程产生的产品（称为生物制剂）和嵌合抗原受体 (CAR-T) 细胞疗法。小分子药物通常以片剂或胶囊的形式口服，但也使用其他药物输送机制。生物制剂通过注射或静脉输液给患者给药。其在线产品包括 Eliquis、Opdivo、Orencia、Pomalyst/Imnovid、Yervoy、Sprycel、Reblozyl、Opdualag、Abecma、Zeposia 等。该公司的产品线包括 Krazati、MRTX1719、RYZ101、KarXT、ORM-6151 和 Repotrectinib。
公司简介
公司代码CELG_r
公司名称Bristol-Myers Squibb Co
上市日期Mar 17, 1980
CEODr. Christopher S. (Chris) Boerner, Ph.D.
员工数量- -
证券类型- -
年结日- -
公司地址Route 206 And Province Line Road
城市PRINCETON
上市交易所- -
国家United States of America
邮编08543
电话16092524621
网址https://www.bms.com
公司代码CELG_r
上市日期Mar 17, 1980
CEODr. Christopher S. (Chris) Boerner, Ph.D.
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Michael R. (Mike) Mcmullen
Mr. Michael R. (Mike) Mcmullen
Independent Director
Independent Director
--
--
Mr. Benjamin Hickey
Mr. Benjamin Hickey
President - RayzeBio Organization, Member of the Leadership Team
President - RayzeBio Organization, Member of the Leadership Team
--
--
Dr. Julia A. Haller, M.D.
Dr. Julia A. Haller, M.D.
Independent Director
Independent Director
--
--
Ms. Lynelle Hoch
Ms. Lynelle Hoch
President, Cell Therapy Organization, Member of the Leadership Team
President, Cell Therapy Organization, Member of the Leadership Team
--
--
Ms. Phyllis R. Yale
Ms. Phyllis R. Yale
Independent Director
Independent Director
--
--
Mr. Greg Scott Meyers
Mr. Greg Scott Meyers
Executive Vice President, Chief Digital and Technology Officer, Member of the Leadership Team
Executive Vice President, Chief Digital and Technology Officer, Member of the Leadership Team
--
--
Ms. Amanda Poole
Ms. Amanda Poole
Executive Vice President, Chief People Officer, Member of the Leadership Team
Executive Vice President, Chief People Officer, Member of the Leadership Team
--
--
Dr. Manuel Hidalgo Medina, M.D., Ph.D.
Dr. Manuel Hidalgo Medina, M.D., Ph.D.
Independent Director
Independent Director
--
--
Mr. Robert Plenge, M.D., Ph.D.
Mr. Robert Plenge, M.D., Ph.D.
Executive Vice President, Chief Research Officer, Head of Research, Member of the Leadership Team
Executive Vice President, Chief Research Officer, Head of Research, Member of the Leadership Team
--
--
Dr. Karen H. Vousden, Ph.D.
Dr. Karen H. Vousden, Ph.D.
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Michael R. (Mike) Mcmullen
Mr. Michael R. (Mike) Mcmullen
Independent Director
Independent Director
--
--
Mr. Benjamin Hickey
Mr. Benjamin Hickey
President - RayzeBio Organization, Member of the Leadership Team
President - RayzeBio Organization, Member of the Leadership Team
--
--
Dr. Julia A. Haller, M.D.
Dr. Julia A. Haller, M.D.
Independent Director
Independent Director
--
--
Ms. Lynelle Hoch
Ms. Lynelle Hoch
President, Cell Therapy Organization, Member of the Leadership Team
President, Cell Therapy Organization, Member of the Leadership Team
--
--
Ms. Phyllis R. Yale
Ms. Phyllis R. Yale
Independent Director
Independent Director
--
--
Mr. Greg Scott Meyers
Mr. Greg Scott Meyers
Executive Vice President, Chief Digital and Technology Officer, Member of the Leadership Team
Executive Vice President, Chief Digital and Technology Officer, Member of the Leadership Team
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 8月16日 周六
更新时间: 8月16日 周六
持股股东
股东类型
持股股东
持股股东
占比
其他
100.00%
持股股东
持股股东
占比
其他
100.00%
股东类型
持股股东
占比
其他
100.00%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
33
482.65K
0.00%
-628.07K
2025Q1
32
482.82K
0.00%
-636.30K
2024Q4
32
943.43K
0.00%
+289.58K
2024Q3
31
601.53K
0.00%
-30.97K
2024Q2
30
511.50K
0.00%
+7.21K
2024Q1
32
397.74K
0.00%
-298.70K
2023Q4
30
495.62K
0.00%
-151.97K
2023Q3
30
535.93K
0.00%
-247.50K
2023Q2
31
542.98K
0.00%
-138.59K
2023Q1
34
441.11K
0.00%
-360.09K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
International Assets Investment Management, LLC
175.00
0%
+175.00
--
Jun 30, 2024
Transcend Capital Advisors, LLC
109.17K
0%
-8.60K
-7.30%
Mar 31, 2025
Davenport Asset Management
83.97K
0%
--
--
Mar 31, 2025
Maven Investment Partners US Ltd.
67.86K
0%
--
--
Mar 31, 2025
BofA Global Research (US)
51.82K
0%
+180.00
+0.35%
Mar 31, 2025
Purkiss Capital Advisors LLC
26.45K
0%
--
--
Mar 31, 2025
Two Sigma Investments, LP
25.68K
0%
-465.00
-1.78%
Mar 31, 2025
MainStreet Advisors
20.00K
0%
--
--
Mar 31, 2025
Watts Gwilliam & Co LLC
20.00K
0%
--
--
Mar 31, 2025
Private Advisor Group LLC
15.00K
0%
--
--
Mar 31, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
